Table 3.
Overall | ||||||||
---|---|---|---|---|---|---|---|---|
Knee ROA N=969 |
Knee sROA‡ N=1,133 |
|||||||
Number of Incident Cases | HR (95% CI) | P-trend¶ | Number of Incident Cases | HR (95% CI) | P-trend¶ | |||
Quartiles total hip aBMD | 0.120 | 0.325 | ||||||
1 (low aBMD) | 47 | Ref | 28 | Ref | ||||
2 (intermediate low aBMD) | 71 | 1.57 (1.07, 2.15) | 50 | 2.15 (1.40, 3.30) | ||||
3 (intermediate high aBMD) | 72 | 1.64 (1.14, 2.36) | 45 | 1.65 (1.02, 2.67) | ||||
4 (high aBMD) | 55 | 1.33 (0.90, 1.99) | 27 | 1.57 (0.86, 2.86) | ||||
Excluding Incident Knee Replacements | ||||||||
Knee sROA‡ N=1,123 |
||||||||
Number of Incident Cases | HR (95% CI) | P-trend¶ | ||||||
Quartiles total hip a BMD | 0.569 | |||||||
1 (low aBMD) | 28 | Ref | ||||||
2 (intermediate aBMD) | 48 | 2.03 (1.31, 3.13) | ||||||
3 (intermediate aBMD) | 39 | 1.44 (0.87, 2.37) | ||||||
4 (high aBMD) | 25 | 1.42 (0.76, 2.64) |
Abbreviations: BMD, Bone Mineral Density; BMI, Body Mass Index; ROA, Radiographic Osteoarthritis; sROA, symptomatic Radiographic Osteoarthritis
All models adjusted for age, sex, race, education, BMI, smoking history, physical activity, history of knee injury, steroid use, and bisphosphonate use. Ns differed from analytic samples because of missing covariate values.
Participants with 1 or neither condition (ROA and symptoms) in a hip at baseline were included
A test of linear trend across quartiles of aBMD was performed based on the ordinal value for each quartile
Values are bolded to indicate statistical significance